ASH releases new VTE guidelinesNovember 28, 2018ThrombosisDVT & Pulmonary EmbolismHematologyVenous ThromboembolismObstetricsOncologyCritical Care
Tofacitinib and TNF inhibitors show similar VTE ratesNovember 20, 2018Rheumatoid ArthritisVenous ThromboembolismThrombosisHematologyRheumatologyCardiologyDVT & Pulmonary Embolism
All patients with VTE have a high risk of recurrenceNovember 20, 2018ThrombosisVenous ThromboembolismHematologyPatient & Survivor CareDVT & Pulmonary EmbolismGeneral Surgery
Prolonged DAPT doesn’t help left main CADNovember 19, 2018ThrombosisCAD & AtherosclerosisInterventional Cardiology & Surgery
Apixaban is safest effective DOAC for stroke prevention in Afib, per AHRQ reportNovember 10, 2018Arrhythmias & EPStrokePreventive CareCardiologyThrombosisCritical Care
CT opens extended window for stroke thrombolysisNovember 1, 2018StrokeNeurologyAcute Coronary SyndromesThrombosis
EHR-guided strategy reduces postop VTE eventsOctober 27, 2018TraumaThrombosisDVT & Pulmonary EmbolismVenous ThromboembolismPerioperative MedicineSurgeryCardiology
OMS721 gains orphan designation for HSCT-associated thrombotic microangiopathyOctober 26, 2018Transfusion MedicineThrombosis
Cardiovascular disease risk unchanged in men with hemophilia AOctober 25, 2018Bleeding DisordersHematologyCardiologyThrombosis
Line complications plague dose-adjusted EPOCH-R in non-Hodgkin lymphomaOctober 25, 2018Aggressive LymphomasThrombosisLymphoma & Plasma Cell DisordersB Cell Lymphoma
VTE risk may be high throughout disease course in uterine serous carcinomaOctober 23, 2018Gynecologic CancerThrombosisDVT & Pulmonary EmbolismSurgery
Rivaroxaban gains indication for prevention of major cardiovascular events in CAD/PADOctober 12, 2018ThrombosisArrhythmias & EPStrokeCAD & AtherosclerosisCardiologyVenous ThromboembolismDVT & Pulmonary Embolism
